Cargando…

Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study

OBJECTIVE: Obesity and diabetes frequently coexist, yet their individual contributions to cardiovascular risk remain debated. We explored cardiovascular disease biomarkers, events, and mortality in the UK Biobank stratified by BMI and diabetes. RESEARCH DESIGN AND METHODS: A total of 451,355 partici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Oliver I., Drozd, Michael, McGowan, Hugo, Giannoudi, Marilena, Conning-Rowland, Marcella, Gierula, John, Straw, Sam, Wheatcroft, Stephen B., Bridge, Katherine, Roberts, Lee D., Levelt, Eylem, Ajjan, Ramzi, Griffin, Kathryn J., Bailey, Marc A., Kearney, Mark T., Cubbon, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369123/ https://www.ncbi.nlm.nih.gov/pubmed/37368983 http://dx.doi.org/10.2337/dc23-0294

Ejemplares similares

Diabetes mellitus and the causes of hospitalisation in people with heart failure
por: Malik, Anam, et al.
Publicado: (2022)

Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study
por: Drozd, Michael, et al.
Publicado: (2021)

Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2022)

Association Between Type 2 Diabetes and Changes in Myocardial Structure, Contractile Function, Energetics, and Blood Flow Before and After Aortic Valve Replacement in Patients With Severe Aortic Stenosis
por: Jex, Nicholas, et al.
Publicado: (2023)

Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy
por: Caspi, Talia, et al.
Publicado: (2020)

Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study
por: Drozd, Michael, et al.
Publicado: (2021)

Reduction of heart failure guideline‐directed medication during hospitalization: prevalence, risk factors, and outcomes
por: Palin, Victoria, et al.
Publicado: (2022)

Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort study
por: Kearney, Jessica, et al.
Publicado: (2021)

Prioritizing symptom management in the treatment of chronic heart failure
por: Koshy, Aaron O., et al.
Publicado: (2020)

Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?
por: McGinlay, Melanie, et al.
Publicado: (2022)

Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2020)

Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data
por: Straw, Sam, et al.
Publicado: (2021)

Correction: Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data
por: Straw, Sam, et al.
Publicado: (2022)

Association of heart failure and its comorbidities with loss of life expectancy
por: Drozd, Michael, et al.
Publicado: (2021)

Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure
por: Cubbon, Richard M., et al.
Publicado: (2018)

Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial
por: Paton, Maria F., et al.
Publicado: (2021)

IGFBP-1 in Cardiometabolic Pathophysiology—Insights From Loss-of-Function and Gain-of-Function Studies in Male Mice
por: Haywood, Natalie J, et al.
Publicado: (2019)

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017)

Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics
por: Pechlivani, Nikoletta, et al.
Publicado: (2021)

Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes
por: Thirunavukarasu, Sharmaine, et al.
Publicado: (2021)

Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction
por: Mercer, Ben N., et al.
Publicado: (2018)

Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction
por: Walker, Andrew M. N., et al.
Publicado: (2018)

Proximal femur fractures in patients taking anti-coagulants: has anything changed?
por: Giannoudi, Marilena, et al.
Publicado: (2022)

Membranous nephropathy in the UK Biobank
por: Hamilton, Patrick, et al.
Publicado: (2023)

Improving the management of left ventricular thrombus in a tertiary cardiology centre: a quality improvement project
por: Rahunathan, Nithusa, et al.
Publicado: (2023)

Evaluation of cardiovascular risk factors in long-term survivors of adult- and childhood-onset brain tumours: a pilot study
por: Kyriakakis, Nikolaos, et al.
Publicado: (2021)

An usual case of bilateral deep venous thrombosis with associated pulmonary embolus
por: Plumptre, Hannah, et al.
Publicado: (2022)

Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
por: Gierula, John, et al.
Publicado: (2022)

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
por: Pearson, Sam, et al.
Publicado: (2019)

Age and cognitive decline in the UK Biobank
por: Cornelis, Marilyn C., et al.
Publicado: (2019)

UK Biobank: opportunities for cardiovascular research
por: Littlejohns, Thomas J, et al.
Publicado: (2019)

Genetic stratification of depression in UK Biobank
por: Howard, David M., et al.
Publicado: (2020)

Quantile Regression for biomarkers in the UK Biobank
por: Wang, Chen, et al.
Publicado: (2023)

Atrial secondary mitral regurgitation: prevalence, characteristics, management, and long-term outcomes
por: Straw, Sam, et al.
Publicado: (2023)

Diabetes Mellitus and Mortality after Acute Coronary Syndrome as a First or Recurrent Cardiovascular Event
por: Cubbon, Richard M., et al.
Publicado: (2008)

Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
por: Iqbal, Hansa, et al.
Publicado: (2020)

Genome-wide association study of multisite chronic pain in UK Biobank
por: Johnston, Keira J. A., et al.
Publicado: (2019)

UK Biobank’s cardiovascular magnetic resonance protocol
por: Petersen, Steffen E., et al.
Publicado: (2016)

A Frailty Index for UK Biobank Participants
por: Williams, Dylan M, et al.
Publicado: (2019)

Characterisation of liver fat in the UK Biobank cohort
por: Wilman, Henry R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_88o5spbuf1skb32suta0lnfdj3